Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Vor Biopharma Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- −1 vs. Q2 2022
- Shares held
- 31.5M
- +386.6K (+1.2%) vs. Q2 2022
- Total value
- $125.5M
- −$29.3M (−18.9%) vs. Q2 2022
- New holders
- 8
- 13 more added
- Sold out
- 9
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 109 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 110 | $0 | 0.00% | +40+57.1% | Added |
| Northwestern Mutual Wealth Management Co | 250 | $1.00K | 0.00% | 00.0% | Unchanged |
| Eagle Bay Advisors LLC | 150 | $1.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 356 | $1.00K | 0.00% | +356 | New |
| Citigroup Inc | 446 | $2.00K | 0.00% | −313−41.2% | Reduced |
| Royal Bank of Canada | 1,572 | $6.00K | 0.00% | +1,572 | New |
| Bank of America Corp | 1,699 | $7.00K | 0.00% | +244+16.8% | Added |
| Simplex Trading, LLC | 3,433 | $13.0K | 0.00% | +3,433 | New |
| Nisa Investment Advisors, LLC | 3,900 | $19.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7,672 | $30.0K | 0.00% | −22,598−74.7% | Reduced |
| Jane Street Group, LLC | 10,412 | $41.0K | 0.00% | +10,412 | New |
| Bourgeon Capital Management LLC | 10,700 | $43.0K | 0.01% | +3,000+39.0% | Added |
| Charles Schwab Investment Management Inc | 10,875 | $44.0K | 0.00% | −30,601−73.8% | Reduced |
| Two Sigma Investments, LP | 14,606 | $58.0K | 0.00% | +14,606 | New |
| Qube Research & Technologies Ltd | 14,834 | $59.0K | 0.00% | −1,463−9.0% | Reduced |
| Chicago Partners Investment Group LLC | 14,549 | $66.0K | 0.00% | +1,659+12.9% | Added |
| Goldman Sachs Group Inc | 19,062 | $76.0K | 0.00% | −8,470−30.8% | Reduced |
| Citadel Advisors LLC | 22,397 | $89.0K | 0.00% | −56,977−71.8% | Reduced |
| Northern Trust Corp | 23,122 | $92.0K | 0.00% | +4,096+21.5% | Added |
| LMR Partners LLP | 26,768 | $107.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 31,900 | $127.0K | 0.00% | +14,600+84.4% | Added |
| Dimensional Fund Advisors LP | 32,945 | $131.0K | 0.00% | +32,945 | New |
| State Street Corp | 41,213 | $164.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 46,660 | $186.0K | 0.00% | +25,148+116.9% | Added |
| Bollard Group LLC | 55,555 | $221.0K | 0.01% | 00.0% | Unchanged |
| Ergoteles LLC | 65,332 | $260.0K | 0.01% | −21,091−24.4% | Reduced |
| Bridgeway Capital Management, LLC | 79,400 | $316.0K | 0.01% | +10,000+14.4% | Added |
| OrbiMed Advisors LLC | 111,808 | $445.0K | 0.01% | −721,525−86.6% | Reduced |
| JPMorgan Chase & Co | 129,080 | $514.0K | 0.00% | −42,297−24.7% | Reduced |
| Geode Capital Management, LLC | 135,598 | $539.0K | 0.00% | +28,223+26.3% | Added |
| Ensign Peak Advisors, Inc | 209,500 | $834.0K | 0.00% | +209,500 | New |
| Ally Bridge Group (NY) LLC | 255,162 | $1.02M | 0.67% | +255,162 | New |
| Thrivent Financial for Lutherans | 302,412 | $1.20M | 0.00% | +15,560+5.4% | Added |
| Millennium Management LLC | 338,921 | $1.35M | 0.00% | +49,979+17.3% | Added |
| OUP Management Co., LLC | 374,714 | $1.49M | 2.32% | 00.0% | Unchanged |
| BlackRock Inc. | 437,621 | $1.74M | 0.00% | −2,497−0.6% | Reduced |
| Artal Group S.A. | 550,000 | $2.19M | 0.11% | 00.0% | Unchanged |
| Sarissa Capital Management LP | 618,000 | $2.46M | 0.28% | 00.0% | Unchanged |
| Vanguard Group Inc | 657,142 | $2.62M | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 857,308 | $3.41M | 0.09% | 00.0% | Unchanged |
| Johnson & Johnson | 1,074,658 | $4.28M | 1.26% | 00.0% | Unchanged |
| Woodline Partners LP | 1,111,123 | $4.42M | 0.06% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,465,925 | $5.83M | 0.04% | +327,157+28.7% | Added |
| Paradigm Biocapital Advisors LP | 1,703,645 | $6.78M | 0.95% | +399,345+30.6% | Added |
| FMR LLC | 3,181,235 | $12.7M | 0.00% | −4,418−0.1% | Reduced |
| 5AM Venture Management, LLC | 6,361,723 | $25.3M | 4.85% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 11,120,973 | $44.3M | 0.94% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −53,074−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −16,132−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −14,856−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,252−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −865−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −46−100.0% | Sold out |